UN

Healthcare · Pharmaceuticals

Unichem Laboratories Ltd (UNICHEMLAB)

₹468.95

Mkt cap
₹3,390 Cr
P/E ratio
28.50
P/B
1.19
Div yield
0.00%
ROE
3.17%
ROCE
4.13%
EPS (TTM)
₹16.45
Book value
₹395
52W range
278–687
Sector
Healthcare

Price history

Previous close

Unichem Laboratories Ltd is involved in pharmaceuticals in Generics, APIs and Contract Manufacturing (CMO) areas. [1]

NSE UNICHEMLABBSE 506690
Health check
Cautious
ValuationFair
ProfitabilityWeak
GrowthModerate
TechnicalsNeutral
52-week range
−31.76% from high
₹469
₹278+68.57% from low₹687
Current
₹468.95
Prev close
₹479.25
Day
−2.15%
Price performance
1D
−1.96%
1W
−5.79%
1M
−3.67%
3M
−9.04%
6M
+27.97%
1Y
+0.80%
YTD
+6.15%

Financials

Revenue, profit & margin
P/E ratio
28.5×
UNICHEMLAB is 15% below the sector median of 33.4×
UNICHEMLAB28.5×
Sector median33.4×
 Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026Trend
Sales416466432483507533587527579521575633640
YoY Sales growth+26%+54%+7%+14%+22%+14%+36%+9%+14%-2%-2%+20%+11%
Expenses407435406443452448503504513476527563566
Operating Profit9312540558684226645487074
OPM %2.1%7%6%8%11%16%14%4.3%11%9%8%11%12%
Other Income679-119491497-372871116-9
Interest7654575787978
Depreciation29322732323130323131313030
Profit before tax-2273-1268276258-9-11293194927
Tax %12%-0%3%74%9%6%8%16%10%10%42%15%19%
Net Profit-2473-1292255853-10-12264114122
EPS in Rs-3.4810.40-18.370.293.508.227.52-1.49-1.6937.541.555.893.16
Raw PDF

Earnings

Results dates & reactions
No upcoming results date on calendar.

Fresh quarters land in the Financials table above, tagged NSE until screener catches up.

Avg earnings-day move +6.78% · closed higher next day 1 of last 2
 Q1FY27Q2FY27
Broadcast11 Aug '264 Nov '26
Earnings day+13.14%+0.42%
+1 day+7.45%−2.00%
+5 days+4.43%−1.24%
+15 days+9.70%—
+30 days+13.02%—
FilingXBRLXBRL

Corporate actions

Last 6 months

No recent corporate actions

Dividends, splits, and bonuses in the last six months show up here.

Shareholding

as of Sep 2026
70.22%Promoter
Promoters70.22%
FIIs2.70%1.80
DIIs9.40%1.06
Public17.67%0.74
Ownership trend

Peers

8 companies
Valuation vs quality
P/E × ROCE · bubble = market cap
NameCMPP/EMkt CapDiv YldNP QtrQtr Profit VarSales QtrQtr Sales VarROCE
Sun Pharma.Inds.₹1,870.0036.464,48,6760.86%1,995−10.53%16,199+11.88%20.53%
Divi's Lab.₹11,150.0086.622,95,9970.27%1,127+63.57%3,676+35.40%21.97%
Torrent Pharma.₹4,668.8081.801,77,5860.81%534−10.03%4,979+50.79%15.19%
Laurus Labs₹2,338.0094.281,26,3250.09%436+126.43%2,206+33.44%17.76%
Zydus Lifesci.₹1,204.2026.511,20,1190.08%928−27.96%7,910+29.17%21.14%
Dr Reddy's Labs₹1,388.0041.411,15,9360.58%913−31.35%8,698−1.48%13.04%
Cipla₹1,388.0036.111,12,1350.94%852−35.05%7,404−2.44%15.49%
Unichem Labs.₹481.5528.523,3900.00%22−7.46%640+10.58%4.13%
Median: 160 Co.₹445.7333.352,0160.08%13+33.73%179+21.23%14.94%

Filings